Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Therapy Name | Hu8F4 |
Synonyms | |
Therapy Description |
Hu8F4 is a monoclonal antibody against the HLA-A2 restricted 9-mer peptide PR1, which may induce cytotoxic immune response against leukemia cells (PMID: 27055866). |
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|---|---|---|---|
Hu8F4 | Hu8F4 is a monoclonal antibody against the HLA-A2 restricted 9-mer peptide PR1, which may induce cytotoxic immune response against leukemia cells (PMID: 27055866). |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|---|---|---|---|---|---|
NCT02530034 | Phase I | Hu8F4 | Hu8F4 in Treating Patients With Advanced Hematologic Malignancies | Active, not recruiting | USA | 0 |